Align Technology (ALGN) Earnings Date & Reports

Key Takeaways

• Align Technology reported Q3 2026 revenue of $1.015 billion, up 1.9% year over year and slightly above the roughly $1.01 billion consensus estimate.
• Adjusted (non-GAAP) diluted earnings per share came in at $2.80, beating analyst expectations of approximately $2.78; GAAP diluted EPS was $1.90.
• Clear Aligner revenue rose 4.2% to $839.3 million, while Imaging Systems and CAD/CAM Services revenue declined 7.6% to $175.5 million.
• Non-GAAP operating margin improved to 24.4%, above guidance, even as softer discretionary dental spending weighed on demand.
• Management guided Q4 2026 revenue to a range of $1.00 billion to $1.02 billion, below the consensus of about $1.05 billion at the time.
• For more context, readers can explore Major News, Today's Price Move, Price Targets, and Forecast on dedicated pages for ALGN.
• Investors seeking additional market insights can also explore Trending AI Robots for AI-driven trading ideas.

Earnings Context and Why It Matters

Align Technology, the maker of the Invisalign clear aligner system and iTero intraoral scanners, is a bellwether for consumer discretionary healthcare spending. Because aligner treatment is often elective and self-funded, Align's results offer an early read on dental-industry demand and patient confidence. Heading into the report, analysts had flagged weakening U.S. clear aligner volumes and trimmed estimates, with several firms downgrading the stock. The Q3 print therefore mattered less for top-line growth alone than for evidence that Align could defend profitability and clear aligner volumes in a softening demand environment while positioning its digital platform and scanner ecosystem for a recovery.

Reported Results

For the third quarter of 2026, Align Technology reported total revenue of $1.015 billion, a 1.9% increase from the prior-year quarter's $995.7 million and modestly above consensus of roughly $1.01 billion. Clear Aligner revenue grew 4.2% year over year to $839.3 million, driven by a 6.6% increase in shipments to a record 690,635 cases. Imaging Systems and CAD/CAM Services revenue fell 7.6% to $175.5 million, reflecting softer capital equipment investment.

Net income climbed to $135.0 million from $56.8 million a year earlier. GAAP diluted earnings per share reached $1.90, compared with $0.78 in Q3 2025. On an adjusted (non-GAAP) basis, diluted EPS was $2.80, slightly ahead of the consensus of about $2.78. GAAP gross margin was 68.7% and non-GAAP gross margin was 70.4%, while non-GAAP operating margin of 24.4% came in above the company's outlook, supported by disciplined expense management and productivity gains.

For Q4 2026, management guided revenue to between $1.00 billion and $1.02 billion, below the consensus of approximately $1.05 billion, and reiterated full-year 2026 revenue of $4.11 billion to $4.13 billion. The company also expects to repurchase up to $300 million of stock in Q4.

AI Screener

Tickeron's AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener is designed to surface trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. For those following companies like Align Technology, the AI Screener offers a structured way to narrow the universe and monitor emerging setups.

Market Reaction and Investor Sentiment

Sentiment into the report was cautious. Analysts had spent October lowering price targets and, in some cases, downgrading the stock amid signs of soft U.S. clear aligner demand and a weaker dental economy. Align's adjusted EPS beat and in-line revenue were offset by Q4 guidance that fell short of consensus, underscoring management's expectation that softer discretionary healthcare spending and cautious capital equipment purchasing will persist. The mixed setup — better-than-expected profitability against a lighter forward outlook — left investors weighing resilient margins and international growth against a still-tempered near-term demand picture.

Forward Outlook and Key Factors to Monitor

Align's fourth-quarter outlook signals that the company expects the challenging demand environment to continue. Management attributed the reduced 2026 revenue expectations to two factors: a lower Systems and Services revenue outlook tied to a mix shift toward lower-priced scanners and more flexible acquisition models, and slightly lower Clear Aligner volume and average selling price (ASP) assumptions driven by product and geographic mix plus foreign exchange.

Investors should watch several signals in the coming quarters. First, clear aligner volume and ASP trends will indicate whether demand is stabilizing or still deteriorating, particularly in North America. Second, iTero scanner placements and the shift toward flexible purchasing models will shape the profitability of the Systems & Services segment. Third, margin execution remains a bright spot, and continued expense discipline will be key to protecting operating margin as revenue growth moderates.

Longer term, Align's investments in direct 3D printing, the NXT Technology platform, and new product categories such as the Invisalign Sports Guard represent potential growth levers, while its roughly $500 million share repurchase plan for 2026 signals management confidence. A sustained recovery in discretionary dental spending remains the primary catalyst to watch.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations